2HE:F:F-Healthequity Inc (EUR)

COMMON STOCK | Health Information Services |

Last Closing

USD 71

Change

0.00 (0.00)%

Market Cap

USD 6.25B

Volume

10.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-08 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
L0T:F GE HEALTHCARE TECH.INC.

N/A

USD 35.91B
4YC:F M3 INC.

N/A

USD 5.81B
6HL0:F R1 RCM Inc

N/A

USD 5.45B
9EH:F Evolent Health Inc

N/A

USD 3.16B
1KJ:F 10X GENOMICS DL -00001

N/A

USD 2.34B
6JM:F JMDC INC.

N/A

USD 1.93B
OC9:F Omnicell Inc

N/A

USD 1.78B
19P:F Phreesia Inc

N/A

USD 1.29B
1XZ:F Ping An Healthcare and Technol..

N/A

USD 1.23B
4LL:F Teladoc Inc

N/A

USD 1.23B

ETFs Containing 2HE:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 19.33% 74% C 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.33% 71% C- 71% C-
Trailing 12 Months  
Capital Gain 6.77% 71% C- 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.77% 68% D+ 50% F
Trailing 5 Years  
Capital Gain 35.47% 82% B 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 35.47% 73% C 51% F
Average Annual (5 Year Horizon)  
Capital Gain 9.24% 80% B- 69% C-
Dividend Return 9.24% 79% B- 62% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 22.43% 68% D+ 58% F
Risk Adjusted Return 41.19% 83% B 63% D
Market Capitalization 6.25B 98% N/A 81% B-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.